Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-84
Closed -$375K 881
2022
Q1
$375K Buy
+84
New +$428K 0.11% 221
2021
Q3
Sell
-2
Closed -$9.64K 1068
2021
Q2
$9.64K Hold
2
﹤0.01% 745
2021
Q1
$9.42K Buy
+2
New +$8.97K ﹤0.01% 597
2019
Q4
Sell
-4
Closed -$14.9K 701
2019
Q3
$14.9K Hold
4
﹤0.01% 405
2019
Q2
$13.5K Buy
4
+3
+300% +$9.62K ﹤0.01% 443
2019
Q1
$2.77K Hold
1
﹤0.01% 428
2018
Q4
$2.44K Hold
1
﹤0.01% 514
2018
Q3
$2.55K Hold
1
﹤0.01% 483
2018
Q2
$3K Hold
1
﹤0.01% 481
2018
Q1
$2.98K Hold
1
﹤0.01% 439
2017
Q4
$3.51K Hold
1
﹤0.01% 442
2017
Q3
$2.85K Hold
1
﹤0.01% 430
2017
Q2
$2.41K Hold
1
﹤0.01% 445
2017
Q1
$2.11K Hold
1
﹤0.01% 391
2016
Q4
$1.67K Hold
1
﹤0.01% 456
2016
Q3
$1.64K Hold
1
﹤0.01% 465
2016
Q2
$1.78K Hold
1
﹤0.01% 407
2016
Q1
$1.73K Hold
1
﹤0.01% 462
2015
Q4
$1.64K Hold
1
﹤0.01% 383
2015
Q3
$1.52K Hold
1
﹤0.01% 408
2015
Q2
$1.34K Hold
1
﹤0.01% 431
2015
Q1
$1.33K Sell
1
-2
-67% -$2.62K ﹤0.01% 439
2014
Q4
$3.83K Buy
+3
New +$3.64K ﹤0.01% 446

Other funds holding NVR

Exane Derivatives's NVR Position: Q2 2022 in Review

Exane Derivatives sold out of NVR (NVR) in Q2 2022, closing a stake of 84 shares — an estimated $375K sold.

Exane Derivatives first reported a position in NVR in Q4 2014 and held it in 23 quarters. The position peaked at $375K in Q1 2022. 522 funds tracked by Wall St. Rank hold NVR as of Q2 2022.

  • Exane Derivatives reported no remaining NVR position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 84 NVR shares in Q2 2022, an estimated $375K.
  • Exane Derivatives first reported a position in NVR in Q4 2014 and held it in 23 quarters.
  • Exane Derivatives's NVR position peaked at $375K in Q1 2022.
  • 522 funds tracked by Wall St. Rank held NVR as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.